Department of Health and Human Services
National Institutes of Health
Toggle navigation
Search
Home
About the Clinical Center
Clinical Trials & You
Participate in a Study
Referring a Patient
How to Search
Contact Us
Search the Studies
Go Back
Searched Result
119 Studies found from all possible combinations of your search terms. Select a protocol that you wish to review.
Protocol Number
Title
Protocol Status
Min-Max Age
Institute
Keywords
001625-HG
Prospective Study of the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders
Participants currently recruited/enrolled
0-100 Years
NHGRI
Retinitis Pigmentosa
19-EI-0056
A Survey Study of Retinitis Pigmentosa (RP) Clinical Measures and Repeatability Testing of Potential Outcome Measures.
Completed Study; data analyses ongoing
12-100 Years
NEI
Retinitis Pigmentosa
16-EI-0024
Rod and Cone Mediated Function in Retinal Disease
Participants currently recruited/enrolled
5-100 Years
NEI
Retinitis Pigmentosa
11-EI-0245
Generation of Induced Pluripotent Stem (iPS) Cell Lines from Somatic Cells of Participants with Eye Diseases and from Somatic Cells of Matched Controls
Participants currently recruited/enrolled
0-120 Years
NEI
Retinitis Pigmentosa
06-EI-0236
National Ophthalmic Genotyping and Phenotyping Network Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
No longer recruiting/follow-up only
0-100 Years
NEI
Retinitis Pigmentosa
002090-C
ComboMATCH Treatment Trial N5: Randomized Trial of Neratinib, a Pan-ErbB Inhibitor alone or in combination with Palbociclib, a CDK4/6 Inhibitor, in Patients with HER2+ Gynecologic Cancers and other Solid Tumors
Participants currently recruited/enrolled
18-120 Years
NCI
14
001961-C
A Molecularly Driven Phase 1b Dose Escalation and Dose Expansion Study of the DNA-PK Inhibitor Peposertib (M3814) in Combination with the ATR Inhibitor M1774
Participants currently recruited/enrolled
18-120 Years
NCI
14
001690-DK
Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation & Metabolic Rate
Participants currently recruited/enrolled
18-65 Years
NIDDK
14
001677-I
A Phase 2b, Double-Blind, Randomized, Placebo-Controlled Trial of Cardamom and Topical Roseomonas in Atopic Dermatitis
Participants currently recruited/enrolled
2-100 Years
NIAID
14
001523-C
A Phase II Study of Lurbinectedin with or without Avelumab in Small Cell Carcinoma of the Bladder (LASER)
Participants currently recruited/enrolled
18-120 Years
NCI
14
001509-I
A Multicenter, Adaptive, Randomized, Controlled Trial Platform To Evaluate Safety and Efficacy of Strategies and Treatments for Hospitalized Patients with Respiratory Infections
Participants currently recruited/enrolled
18-100 Years
NIAID
14
001066-DA
Orexin's Role in The Neurobiology of Substance Use Disorder
Participants currently recruited/enrolled
18-60 Years
NIDA
14
001058-DK
A Phase 1b/2a Open-label Multiple-ascending Dose Exploratory Study of CRN04894 in ACTH-dependent Cushing's Syndrome (Cushing's Disease or Ectopic ACTH Syndrome)
Participants currently recruited/enrolled
18-75 Years
NIDDK
14
001004-C
A Phase 1b/2 Basket Study of ACR-368 as Monotherapy and in Combination with Gemcitabine in Adult Subjects with Platinum-Resistant Ovarian Carcinoma, Endometrial Adenocarcinoma, and Urothelial Carcinoma Based on Acrivon Oncosignature(R) Status
Participants currently recruited/enrolled
18-120 Years
NCI
14
000954-C
A Phase 1/2 Single Arm Open-Label Clinical Trial of TC-510 In Patients with Advanced Mesothelin-Expressing Cancer
No longer recruiting/follow-up only
18-120 Years
NCI
14
000889-I
VRC 615: A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB-0115-AB (VRC01.23LS), Administered Intravenously or Subcutaneously to Healthy Adults
No longer recruiting/follow-up only
18-60 Years
NIAID
14
000780-D
A Phase 2 Study of Denosumab for Prevention of Skeletal Disease Progression in Children with Fibrous Dysplasia
Participants currently recruited/enrolled
4-14 Years
NIDCR
14
000687-I
VRC 322/DMID 21-0016: A Phase I, Dose Escalation, Open-Label Clinical Trial to Evaluate Safety, Tolerability and Immunogenicity of a Nipah Virus (NiV) mRNA Vaccine, mRNA-1215, in Healthy Adults
No longer recruiting/follow-up only
18-60 Years
NIAID
14
000569-C
Clinical Study of Bioactivity of Low Dose Apalutamide in Prostate Cancer Patients Scheduled for Prostatectomy
Participants currently recruited/enrolled
18-125 Years
NCI
14
000473-C
A Randomized Phase II Study of Systemic Chemotherapy with or without HAI FUDR-Dexamethasone in Patients with Unresectable Intrahepatic Cholangiocarcinoma
Participants currently recruited/enrolled
18-125 Years
NCI
14
000421-AA
Individual Variations of Taste and Smell Perception in Alcohol Use Disorder (AUD)
Participants currently recruited/enrolled
18-65 Years
NIAAA
14
000406-AA
Addictions Neuroclinical Assessment
Enrolling by Invitation
18-99 Years
NIAAA
14
000310-CH
A Phase 1/2, First-in-Human, Open-Label, Dose-Escalation Study of the Safety and Efficacy of Gene Therapy for Congenital Adrenal Hyperplasia through Administration of an Adeno-Associated Virus (AAV) Serotype 5-Based Recombinant Vector Encoding the Human
Participants currently recruited/enrolled
18-99 Years
NICHD
14
000241-CH
Phase II Trial of Liraglutide (Saxenda(R), Novo Nordisk) in Adolescents with Obesity After Sleeve Gastrectomy: A Pilot Open-Label Study
Completed Study; data analyses ongoing
12-20 Years
NICHD
14
000194-C
A Phase I Trial of ProAgio, an anti- alpha-v-beta3 Integrin Cytotoxin, for Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies
Participants currently recruited/enrolled
18-120 Years
NCI
14
000123-CC
Evaluation of Atherosclerotic Plaques in Abdominal CT Studies
No longer recruiting/follow-up only
30-90 Years
CC
14
000110-H
A Phase II Study Evaluating Fostamatinib for Hospitalized Adults with COVID-19
Completed Study; data analyses ongoing
18-125 Years
NHLBI
14
000051-N
NIH Investigative Deep Phenotyping Study of Gulf War Veteran Health (Project NIH IN-DEPTH)
Participants currently recruited/enrolled
48-70 Years
NINDS
14
000049-H
Evaluation of the Safety,Tolerability, Pharmacokinetics, and Pharmacodynamics of Long-term Mitapivat Dosing in Subjects with Stable Sickle Cell Disease: An Extension of a Phase I Pilot Study of Mitapivat
No longer recruiting/follow-up only
18-70 Years
NHLBI
14
000036-AA
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Study of Safety, Tolerability, and Bioeffects of Alirocumab in Non-treatment Seeking Heavy Drinkers
Participants currently recruited/enrolled
21-65 Years
NIAAA
14
21-C-0019
Phase I Study of Anti-CD22 Chimeric Receptor T Cells in Patients with Relapsed/Refractory Hairy Cell Leukemia and Variant
Participants currently recruited/enrolled
18-125 Years
NCI
14
20-M-0159
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
Participants currently recruited/enrolled
14-25 Years
NIMH
14
20-EI-0052
A Phase I/IIa Trial for Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated with Age-Related Macular Degeneration
Participants currently recruited/enrolled
55-95 Years
NEI
14
20-E-0108
A Prospective Natural History Study of Smoking, Immune Cell Profiles, Epigenetics and COVID-19
Completed Study; data analyses ongoing
30-55 Years
NIEHS
14
20-C-0150
Phase II Randomized Trial of Bethesda Protocol Compared to Cambridge Method for Detection of Early Stage Gastric Cancer in CDH1 Mutation Carriers
Participants currently recruited/enrolled
18-125 Years
NCI
14
20-C-0028
Phase 1/2 Study of Anti-CD33 Chimeric Antigen Receptor-Expressing T Cells (CD33CART) in Children and Young Adults with Relapsed/Refractory Acute Myeloid Leukemia
Participants currently recruited/enrolled
3-35 Years
NCI
14
20-C-0022
Phase II trial of VB-111 in Combination with Nivolumab in Patients with Metastatic Colorectal Cancer (mCRC)
Completed Study; data analyses ongoing
18-125 Years
NCI
14
20-AA-0115
COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study
Participants currently recruited/enrolled
18-100 Years
NIAAA
14
19-I-0126
Systems Analyses of the Immune Response to the Seasonal Influenza Vaccine
Completed Study; data analyses ongoing
18-125 Years
NIAID
14
19-H-0097
A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Escalating Multiple Oral Doses of AG-348 in Subjects with Stable Sickle Cell Disease
Completed Study; data analyses ongoing
18-70 Years
NHLBI
14
19-CC-0063
Impact of Steady State Cobicistat and Darunavir/Cobicistat on the Pharmacokinetics and Pharmacodynamics of Oral Anticoagulants (Rivaroxaban, Apixaban) in Healthy Volunteers
Completed Study; data analyses ongoing
18-65 Years
CC
14
19-C-0116
A Phase 2 Study of Acalabrutinib with DA-EPOCH-R or R-CHOP for Patients with Untreated Diffuse Large B-cell Lymphoma
Participants currently recruited/enrolled
18-125 Years
NCI
14
19-C-0016
Natural History and Biospecimen Acquisition Study for Children and Adults with Rare Solid Tumors
Participants currently recruited/enrolled
0-125 Years
NCI
14
18-I-0039
Challenge Infection of Healthy Adult Volunteers with RSV A2
Completed Study; data analyses ongoing
18-50 Years
NIAID
14
18-D-0114
An Open Label Pilot Study of Denosumab Treatment for Fibrous Dysplasia
Completed Study; data analyses ongoing
18-125 Years
NIDCR
14
18-CC-0079
Pilot RCT of Web-based Behavioral Sleep Intervention for Individuals with Alcohol Use Disorder
Completed Study; data analyses ongoing
18-65 Years
CC
14
17-M-0060
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
Participants currently recruited/enrolled
18-65 Years
NIMH
14
17-DA-0093
Exploring Gut-Brain and Brain-Gut Interactions in Alcohol Use Disorder via Microbiota Investigations: A Pilot Study
Completed Study; data analyses ongoing
21-70 Years
NIDA
14
17-CC-0111
Pilot Study Characterizing Aerobic Exercise in Women with Systemic Lupus Erythematosus (Exercise SLE Pilot).
Completed Study; data analyses ongoing
21-80 Years
CC
14
17-C-0048
Anti-CD30 CAR T Cells with Fully-human Binding Domains for Treating CD30-expressing Lymphomas Including Anaplastic Large Cell Lymphomas
Completed Study; data analyses ongoing
18-73 Years
NCI
14
17-C-0009
Phase I Trial of Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide (tmz) Followed by Randomized Phase II Trial of Zotiraciclib (TG02) plus Temozolomide versus Temozolomide alone in Adults with Recurrent Anaplastic Astrocytoma and Glioblastom
Completed Study; data analyses ongoing
18-125 Years
NCI
14
17-AA-0171
Nicotinic Receptor Genetic Variation and Alcohol Reward
Participants currently recruited/enrolled
21-60 Years
NIAAA
14
16-I-0053
A Multicenter Study of the Immunogenicity of Recombinant Vesicular Stomatitis Vaccine for Ebola-Zaire (rVSVdeltaG-ZEBOV GP) for Pre-Exposure Prophylaxis in Individuals at Potential Occupational Risk for Ebola Virus Exposure (PREPARE)
No longer recruiting/follow-up only
18-125 Years
NIAID
14
16-DA-N140
Effects of a New Behavioral Intervention on Alcohol Craving and Drinking
Participants currently recruited/enrolled
21-65 Years
NIDA
14
16-CC-0162
Longitudinal Changes in the Oral and Gut Microbiome of Individuals with Alcohol Dependence
Completed Study; data analyses ongoing
18-125 Years
CC
14
16-C-0060
A Phase 1b/2 Study of alvelestat (MPH966), an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation
Participants currently recruited/enrolled
18-125 Years
NCI
14
15-M-0182
Psychological Treatments for Youth with Severe Irritability
Participants currently recruited/enrolled
8-17 Years
NIMH
14
15-CH-0096
Children's Growth and Behavior Study
Participants currently recruited/enrolled
8-100 Years
NICHD
14
15-C-0076
A Pilot Study of Long Term TARP Vaccination Using A Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139
Completed Study; data analyses ongoing
18-125 Years
NCI
14
15-C-0075
A Randomized, Placebo-Controlled Phase II Study of Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men with Stage D0 Prostate Cancer
Completed Study; data analyses ongoing
18-125 Years
NCI
14
14-N-0086
Deep Brain Stimulation Therapy in Movement Disorders
Participants currently recruited/enrolled
18-125 Years
NINDS
14
14-N-0083
Neural Basis of Decision Making Deficits in Traumatic Brain Injury
Participants currently recruited/enrolled
18-60 Years
NINDS
14
14-N-0061
Noninvasive Pre-surgical Evaluation of Patients with Focal Epilepsy and Establishment of a Normative Imaging Database
Participants currently recruited/enrolled
8-120 Years
NINDS
14
14-I-0206
Novel Genetic Disorders of the Immune System
Participants currently recruited/enrolled
3-99 Years
NIAID
14
14-I-0194
Screening of Volunteers for Clinical Trials of Investigational or Licensed Vaccines or Antiviral Products
Participants currently recruited/enrolled
18-120 Years
NIAID
14
14-I-0146
The Pathogenesis and Genetics of Disseminated or Refractory Coccidioidomycosis
Participants currently recruited/enrolled
2-100 Years
NIAID
14
14-I-0124
PET Imaging and Lymph Node Assessment of IRIS in Persons With AIDS
Participants currently recruited/enrolled
18-125 Years
NIAID
14
14-I-0091
Analysis of Patients Treated for Chronic Granulomatous Disease Since January 1, 1995
Completed Study; data analyses ongoing
3-125 Years
NIAID
14
14-I-0081
A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Subcutaneous Benralizumab (MEDI-563) in Reducing Eosinophilia in Subjects with Hypereosinophilic Syndrome (HES)
No longer recruiting/follow-up only
18-75 Years
NIAID
14
14-I-0063
An Open-Label, Proof-of-Concept Study to Evaluate the Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects with Hypereosinophilic Syndrome
No longer recruiting/follow-up only
18-125 Years
NIAID
14
14-I-0020
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Participants currently recruited/enrolled
18-65 Years
NIAID
14
14-I-0009
Characterization and Management of Patients with HIV-1 Infection Who Experience Virologic Failure Despite Combination Antiretroviral Therapy
Completed Study; data analyses ongoing
18-100 Years
NIAID
14
14-HG-0125
Insights Into Microbiome and Environmental Contributions to Sickle Cell Disease and Leg Ulcers
Participants currently recruited/enrolled
18-120 Years
NHGRI
14
14-HG-0071
Clinical and Basic Investigations into Known and Suspected Congenital Disorders of Glycosylation
Participants currently recruited/enrolled
1-80 Years
NHGRI
14
14-HG-0055
Study on Moebius Syndrome and Other Congenital Facial Weakness Disorders
Completed Study; data analyses ongoing
2-80 Years
NHGRI
14
14-HG-0048
Genomics, Environmental Factors and Social Determinants of Cardiovascular Disease in African-Americans Study (GENE-FORECAST)
Completed Study; data analyses ongoing
21-65 Years
NHGRI
14
14-H-0188
Prospective Evaluation of Next Generation CT Reconstruction
Participants currently recruited/enrolled
18-99 Years
NHLBI
14
14-H-0077
Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-Thalassemia in Individuals with Higher Risk of Transplant Failure
No longer recruiting/follow-up only
4-80 Years
NHLBI
14
14-EI-0171
The Focal Electro-Oculogram in Macular Disease
Completed Study; data analyses ongoing
10-100 Years
NEI
14
14-EI-0064
Whole Exome and Whole Genome Sequencing for Genotyping of Inherited and Congenital Eye Conditions
Participants currently recruited/enrolled
0-120 Years
NEI
14
14-DK-0195
Acute Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitor on Bone Metabolism in Healthy Volunteers
Completed Study; data analyses ongoing
18-125 Years
NIDDK
14
14-DK-0060
Famine from Feast: Linking Vitamin C, Red Blood Cell Fragility, and Diabetes
Participants currently recruited/enrolled
18-65 Years
NIDDK
14
14-CH-0028
Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome
Participants currently recruited/enrolled
18-80 Years
NIDDK
14
14-CC-0201
A Randomized Controlled Trial to Determine the Effectiveness of a Stress Reduction Intervention in Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients
Completed Study; data analyses ongoing
18-125 Years
CC
14
14-CC-0143
Sleep Disturbance and Relapse in Individuals with Alcohol Dependence: An Exploratory Mixed Methods Study
Completed Study; data analyses ongoing
18-125 Years
CC
14
14-CC-0027
The NIH Exercise Therapy for Advanced Lung Disease Trials: Response and Adaptation to Aerobic Exercise in Patients with Interstitial Lung Disease
Completed Study; data analyses ongoing
21-80 Years
CC
14
14-C-0163
Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1: Clinical, Histopathologic, and Genomic Analysis
Completed Study; data analyses ongoing
10-125 Years
NCI
14
14-C-0161
Phase I Trial of the Combination of Bortezomib and Clofarabine in Adults with Refractory Solid Tumors, Lymphomas, or Myelodysplastic Syndromes
Participants currently recruited/enrolled
18-120 Years
NCI
14
14-C-0157
Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib, Rituximab (TEDDI-R) in Primary CNS Lymphoma
Participants currently recruited/enrolled
18-125 Years
NCI
14
14-C-0156
A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) In BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, and High Grade Serous Ovarian Cancer
Completed Study; data analyses ongoing
18-125 Years
NCI
14
14-C-0128
Collection of Pharmacokinetic and Probe Substrate Samples from Participants with Unanticipated Response, Significant Toxicity or Concern of Future Toxicity
Enrolling by Invitation
2-125 Years
NCI
14
14-C-0116
A Randomized Controlled Trial Evaluating an Enhanced Physical Activity Intervention to Improve Cognitive Late Effects in Children Treated with Cranial Radiation for Brain Tumors
Participants currently recruited/enrolled
8-125 Years
NCI
14
14-C-0105
Tissue Procurement and Natural History Study of Patients with Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
Participants currently recruited/enrolled
18-125 Years
NCI
14
14-C-0104
A Phase II Study Using Autologous Young Tumor-Infiltrating Lymphocytes Derived from Patients with Non-Small Cell Lung Cancer Following Non-Myeloablative Lymphocyte Depleting Preparative Regimen
Participants currently recruited/enrolled
18-72 Years
NCI
14
14-C-0079
An Exploratory Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults with Cancer and Other Chronic Illnesses
No longer recruiting/follow-up only
18-125 Years
NCI
14
14-C-0037
A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer
Completed Study; data analyses ongoing
18-125 Years
NCI
14
14-C-0036
A Randomized, Prospective, Phase II Study to Determine the Efficacy of Bacillus Calmette-Guerin (BCG) Given in Combination with PANVAC[TM] Versus BCG Given Alone in Adults with High Grade Non-Muscle Invasive Bladder Cancer (NMIBC) Who Failed at Least 1 I
Completed Study; data analyses ongoing
18-125 Years
NCI
14
14-C-0004
A Multicenter Phase 2 Study of the Bruton's Tyrosine Kinase Inhibitor PCI-32765 (Ibrutinib) for Treatment of Relapsed Hairy Cell Leukemia
No longer recruiting/follow-up only
18-125 Years
NCI
14
14-C-0001
Phase II Study of Axitinib (AG-013736) with Evaluation of the VEGF-pathway in Metastatic, Recurrent or Primary Unresectable Pheochromocytoma/Paraganglioma
Completed Study; data analyses ongoing
18-125 Years
NCI
14
14-AR-0200
Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
Participants currently recruited/enrolled
3-125 Years
NIAMS
14
14-AA-0192
Brain Inflammation and Function in Alcoholism
Completed Study; data analyses ongoing
30-75 Years
NIAAA
14
14-AA-0181
NIAAA Natural History Protocol
Participants currently recruited/enrolled
18-100 Years
NIAAA
14
14-AA-0144
Reliability Of The Human Brain Connectome
Completed Study; data analyses ongoing
18-125 Years
NIAAA
14
14-AA-0080
Characterization Imaging Instruments for Addiction Neuroimaging Assessments
Participants currently recruited/enrolled
18-125 Years
NIAAA
14
14-AA-0066
Behavioral and Functional Task Development, Implementation, and Testing
Participants currently recruited/enrolled
18-65 Years
NIAAA
14
13-C-0152
A Phase I Study of Autologous Activated Natural Killer (NK) Cells +/- rhIL15 in Children and Young Adults with Refractory Solid Tumors
Completed Study; data analyses ongoing
2-29 Years
NCI
14
12-H-0150
Eltrombopag Added to Standard Immunosuppression in Treatment-Naive Severe Aplastic Anemia
Participants currently recruited/enrolled
2-99 Years
NHLBI
14
12-E-0050
The Role of Gonadotropin Pulsations in the Regulation of Puberty and Fertility
Participants currently recruited/enrolled
14-125 Years
NIEHS
14
12-DK-0097
Energy Expenditure Responses to Different Temperatures
Participants currently recruited/enrolled
18-75 Years
NIDDK
14
11-CC-0088
Effect of Aerobic Exercise Training on Cardiorespiratory Fitness in Patients with Traumatic Brain Injury
Completed Study; data analyses ongoing
21-45 Years
CC
14
11-C-0140
A Phase I Study of Gemcitabine, Carboplatin and Lenalidomide (GCL) for Treatment of Patients with Advanced/Metastatic Urothelial Carcinoma (UC) and Other Solid Tumors
Completed Study; data analyses ongoing
18-125 Years
NCI
14
09-N-0039
A Phase I Study of the Intrathecal Administration of Resiniferatoxin for Treating Severe Refractory Pain Associated with Advanced Cancer
Participants currently recruited/enrolled
18-99 Years
NINDS
14
09-H-0239
Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees at Baseline, and After Immunization with the H1N1 or Seasonal Influenza Vaccines
Completed Study; data analyses ongoing
18-125 Years
NHLBI
14
08-H-0186
Safety and the Anti- Tumor Effects of Escalating Doses of Adoptively Infused Ex Vivo Expanded Autologous Natural Killer (NK) Cells Against Metastatic Cancers or Hematological Malignancies Sensitized to NK-TRAIL Cytotoxicity with Bortezomib
Completed Study; data analyses ongoing
18-70 Years
NHLBI
14
07-CH-0008
Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
Completed Study; data analyses ongoing
18-85 Years
NIDDK
14
07-C-0195
Phase II Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation Using 8/8 and 7/8 HLA-matched Unrelated Donors and Utilizing Two Graft-versus-Host Disease Prophylaxis Regimens for the Trea
Completed Study; data analyses ongoing
18-74 Years
NCI
14
06-M-0214
PET Measurement of Regional Rates of Cerebral Protein Synthesis in Subjects with Fragile X Syndrome
Completed Study; data analyses ongoing
18-24 Years
NIMH
14
05-C-0252
Phase III Randomized Study of R-CHOP v. Dose-Adjusted EPOCH-R with Molecular Profiling in Untreated de Novo Diffuse Large B-Cell Lymphomas
Completed Study; data analyses ongoing
18-125 Years
NCI
14
96-CH-0033
An Open, Randomized, Long-Term Clinical Trial of Flutamide, Testolactone, and Reduced Hydrocortisone Dose vs. Conventional Treatment of Children with Congenital Adrenal Hyperplasia
Completed Study; data analyses ongoing
2-18 Years
NICHD
14